SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-029911
Filing Date
2024-08-01
Accepted
2024-08-01 16:05:14
Documents
1
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3114
  Complete submission text file 0001493152-24-029911.txt   4627
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address LAAG NIEUWKOOP 10 KOCKENGEN P7 3628 GC
Business Address
Schellens Johannes Henricus Matthias (Reporting) CIK: 0002025872 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39717 | Film No.: 241166526